Cargando…
Changes in Retinal Nerve Fiber Layer Thickness after Multiple Injections of Novel VEGF Decoy Receptor Conbercept for Various Retinal Diseases
Conbercept is a recombinant fusion protein with high affinity for all vascular endothelial growth factor isoforms and placental growth factor. The repeated intravitreal injection of conbercept may cause intraocular pressure (IOP) fluctuations and long-term suppression of neurotrophic cytokines, whic...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5138833/ https://www.ncbi.nlm.nih.gov/pubmed/27922068 http://dx.doi.org/10.1038/srep38326 |
_version_ | 1782472139219140608 |
---|---|
author | Zhang, Zhihua Yang, Xiaolu Jin, Huiyi Qu, Yuan Zhang, Yuan Liu, Kun Xu, Xun |
author_facet | Zhang, Zhihua Yang, Xiaolu Jin, Huiyi Qu, Yuan Zhang, Yuan Liu, Kun Xu, Xun |
author_sort | Zhang, Zhihua |
collection | PubMed |
description | Conbercept is a recombinant fusion protein with high affinity for all vascular endothelial growth factor isoforms and placental growth factor. The repeated intravitreal injection of conbercept may cause intraocular pressure (IOP) fluctuations and long-term suppression of neurotrophic cytokines, which could lead to retinal nerve fiber layer (RNFL) damage. This retrospective fellow-eye controlled study included 98 eyes of 49 patients. The changes in IOP and RNFL thickness as well as the correlation between RNFL changes and associated factors were evaluated. The IOP value between the baseline and the last follow-up visit in the injection group and the IOP value of the last follow-up visit between the injection and non-injection groups were not significantly different (p = 0.452 and 0.476, respectively). The global average thickness of the RNFL (μm) in the injection group decreased from 108.9 to 106.1; however, the change was not statistically significant (p = 0.118). No significant difference in the average RNFL thickness was observed at the last follow-up visit between the injection and non-injection groups (p = 0.821). The type of disease was the only factor associated with RNFL thickness changes. In conclusion, repeated intravitreal injections with 0.05 mL conbercept revealed an excellent safety profile for RNFL thickness, although short-term IOP changes were observed. |
format | Online Article Text |
id | pubmed-5138833 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-51388332016-12-16 Changes in Retinal Nerve Fiber Layer Thickness after Multiple Injections of Novel VEGF Decoy Receptor Conbercept for Various Retinal Diseases Zhang, Zhihua Yang, Xiaolu Jin, Huiyi Qu, Yuan Zhang, Yuan Liu, Kun Xu, Xun Sci Rep Article Conbercept is a recombinant fusion protein with high affinity for all vascular endothelial growth factor isoforms and placental growth factor. The repeated intravitreal injection of conbercept may cause intraocular pressure (IOP) fluctuations and long-term suppression of neurotrophic cytokines, which could lead to retinal nerve fiber layer (RNFL) damage. This retrospective fellow-eye controlled study included 98 eyes of 49 patients. The changes in IOP and RNFL thickness as well as the correlation between RNFL changes and associated factors were evaluated. The IOP value between the baseline and the last follow-up visit in the injection group and the IOP value of the last follow-up visit between the injection and non-injection groups were not significantly different (p = 0.452 and 0.476, respectively). The global average thickness of the RNFL (μm) in the injection group decreased from 108.9 to 106.1; however, the change was not statistically significant (p = 0.118). No significant difference in the average RNFL thickness was observed at the last follow-up visit between the injection and non-injection groups (p = 0.821). The type of disease was the only factor associated with RNFL thickness changes. In conclusion, repeated intravitreal injections with 0.05 mL conbercept revealed an excellent safety profile for RNFL thickness, although short-term IOP changes were observed. Nature Publishing Group 2016-12-06 /pmc/articles/PMC5138833/ /pubmed/27922068 http://dx.doi.org/10.1038/srep38326 Text en Copyright © 2016, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Zhang, Zhihua Yang, Xiaolu Jin, Huiyi Qu, Yuan Zhang, Yuan Liu, Kun Xu, Xun Changes in Retinal Nerve Fiber Layer Thickness after Multiple Injections of Novel VEGF Decoy Receptor Conbercept for Various Retinal Diseases |
title | Changes in Retinal Nerve Fiber Layer Thickness after Multiple Injections of Novel VEGF Decoy Receptor Conbercept for Various Retinal Diseases |
title_full | Changes in Retinal Nerve Fiber Layer Thickness after Multiple Injections of Novel VEGF Decoy Receptor Conbercept for Various Retinal Diseases |
title_fullStr | Changes in Retinal Nerve Fiber Layer Thickness after Multiple Injections of Novel VEGF Decoy Receptor Conbercept for Various Retinal Diseases |
title_full_unstemmed | Changes in Retinal Nerve Fiber Layer Thickness after Multiple Injections of Novel VEGF Decoy Receptor Conbercept for Various Retinal Diseases |
title_short | Changes in Retinal Nerve Fiber Layer Thickness after Multiple Injections of Novel VEGF Decoy Receptor Conbercept for Various Retinal Diseases |
title_sort | changes in retinal nerve fiber layer thickness after multiple injections of novel vegf decoy receptor conbercept for various retinal diseases |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5138833/ https://www.ncbi.nlm.nih.gov/pubmed/27922068 http://dx.doi.org/10.1038/srep38326 |
work_keys_str_mv | AT zhangzhihua changesinretinalnervefiberlayerthicknessaftermultipleinjectionsofnovelvegfdecoyreceptorconberceptforvariousretinaldiseases AT yangxiaolu changesinretinalnervefiberlayerthicknessaftermultipleinjectionsofnovelvegfdecoyreceptorconberceptforvariousretinaldiseases AT jinhuiyi changesinretinalnervefiberlayerthicknessaftermultipleinjectionsofnovelvegfdecoyreceptorconberceptforvariousretinaldiseases AT quyuan changesinretinalnervefiberlayerthicknessaftermultipleinjectionsofnovelvegfdecoyreceptorconberceptforvariousretinaldiseases AT zhangyuan changesinretinalnervefiberlayerthicknessaftermultipleinjectionsofnovelvegfdecoyreceptorconberceptforvariousretinaldiseases AT liukun changesinretinalnervefiberlayerthicknessaftermultipleinjectionsofnovelvegfdecoyreceptorconberceptforvariousretinaldiseases AT xuxun changesinretinalnervefiberlayerthicknessaftermultipleinjectionsofnovelvegfdecoyreceptorconberceptforvariousretinaldiseases |